Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122026613 | 12202661 | 3 | F | 201411 | 20160818 | 20160322 | 20160901 | EXP | US-ACORDA-ACO_122072_2016 | ACORDA | 36.66 | YR | F | Y | 107.94000 | KG | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122026613 | 12202661 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Unknown | 10 MG, QD | 000079809 | 22250 | 10 | MG | TABLET | QD | |||||
| 122026613 | 12202661 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
| 122026613 | 12202661 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
| 122026613 | 12202661 | 4 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
| 122026613 | 12202661 | 5 | C | TYSABRI | NATALIZUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 122026613 | 12202661 | 6 | C | LYRICA | PREGABALIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 122026613 | 12202661 | 7 | C | Megestrol | MEGESTROL | 1 | Unknown | UNK | U | 0 | |||||||||
| 122026613 | 12202661 | 8 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | UNK, PRN | U | 0 | |||||||||
| 122026613 | 12202661 | 9 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | UNK, PRN | U | 0 | |||||||||
| 122026613 | 12202661 | 10 | C | Glucosamine and Chondroitin | CHONDROITIN SULFATE (BOVINE)GLUCOSAMINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122026613 | 12202661 | 1 | Gait disturbance |
| 122026613 | 12202661 | 5 | Product used for unknown indication |
| 122026613 | 12202661 | 6 | Product used for unknown indication |
| 122026613 | 12202661 | 7 | Product used for unknown indication |
| 122026613 | 12202661 | 8 | Product used for unknown indication |
| 122026613 | 12202661 | 9 | Product used for unknown indication |
| 122026613 | 12202661 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122026613 | 12202661 | HO |
| 122026613 | 12202661 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122026613 | 12202661 | Abasia | |
| 122026613 | 12202661 | Arthralgia | |
| 122026613 | 12202661 | Asthenia | |
| 122026613 | 12202661 | Drug effect decreased | |
| 122026613 | 12202661 | Dyskinesia | |
| 122026613 | 12202661 | Fall | |
| 122026613 | 12202661 | Gait disturbance | |
| 122026613 | 12202661 | Inappropriate schedule of drug administration | |
| 122026613 | 12202661 | Limb injury | |
| 122026613 | 12202661 | Musculoskeletal stiffness | |
| 122026613 | 12202661 | Therapy cessation | |
| 122026613 | 12202661 | Tibia fracture | |
| 122026613 | 12202661 | Type 2 diabetes mellitus | |
| 122026613 | 12202661 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122026613 | 12202661 | 2 | 201204 | 201501 | 0 | |
| 122026613 | 12202661 | 3 | 201507 | 201602 | 0 | |
| 122026613 | 12202661 | 4 | 201605 | 0 | ||
| 122026613 | 12202661 | 7 | 201510 | 0 |